Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis-Reference-Cited by-同舟云学术

Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis

Published:2012-12 Issue:10 Volume:34 Page:923-930
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Ticha Veronika¹,Kalincik Tomas¹²,Havrdova Eva¹

Affiliation:

1. Department of Neurology and Center of Clinical NeuroscienceCharles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Czech Republic

2. MSBase FoundationMelbourne Brain Centre at Royal Melborune Hospital, University of Melbourne, Parkville, Vic., Australia

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1179/1743132812Y.0000000090

Reference28 articles.

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial

2. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

3. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial

4. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

5. Measures in the first year of therapy predict the response to interferon β in MS

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NÖROBEHÇET SENDROMUNDA KLİNİK, DEMOGRAFİK VE RADYOLOJİK BULGULAR;Kocatepe Tıp Dergisi;2021-01-05

2. Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society;Revue Neurologique;2020-12

3. Neurobehçet, multiple sclerosis or overlap syndrome? A case report;Neurological Sciences;2018-04-26

4. Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease;Therapeutic Advances in Neurological Disorders;2016-01-21

5. The inhibin-βC subunit is down-regulated, while inhibin-βE is up-regulated by interferon-β1a in Ishikawa carcinoma cell line;Archives of Gynecology and Obstetrics;2013-04-12